Trial Profile
A Randomized, Parallel Group, Double-blind, Multi-center Study Comparing the Efficacy and Safety of AVANDAMET and Metformin After 80 Weeks of Treatment.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Aug 2023
Price :
$35
*
At a glance
- Drugs Rosiglitazone/metformin (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline; GSK
- 01 Nov 2011 Efficacy and bone mineral density results published in Diabetes, Obesity and Metabolism.
- 24 Sep 2010 Primary endpoint 'Proportion of glycosylated haemoglobin' has been met.
- 24 Sep 2010 Results were reported at the 46th Annual Meeting of the European Association for the Study of Diabetes.